news
Adaptive therapy inhibits chemo-resistance in study
25 February 2016 | By Victoria White
Adaptive therapy is based on evolutionary principals and aims to keep resistant cells in check by maintaining a population of chemo-sensitive cells...
List view / Grid view
Hit-to-Lead
news
Pancreatic cancer identified as four separate diseases
24 February 2016 | By Victoria White
A study has revealed that pancreatic cancer is actually four separate diseases, each with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments...
news
OncoQR ML’s TYG100 induces strong immune response in pancreatic cancer
23 February 2016 | By Victoria White
In a highly relevant non-human primate model TYG100 was able to induce a strong and clinically relevant immune response...
article
Directing a weaponised attack on cancer with Natural Killer Receptor T-Cells
23 February 2016 | By Dr Frédéric Lehmann, VP Immuno-Oncology, Celyad
Natural killer receptor T-cells have the potential to become a real game changing treatment for patients with cancer. Here, Dr Frédéric Lehmann, VP Immuno-Oncology, Celyad, discusses this new cancer fighting technology...
news
Desktop Genetics receives grant for site-specific epigenetic CRISPR editing
23 February 2016 | By Victoria White
Given the key role of epigenetics in all tumour types, Desktop Genetics' research has wide potential applications across all histological types of cancer...
news
Pherecydes Pharma appoints Fanneau de La Horie as CEO
22 February 2016 | By Katie Sadler
Pherecydes Pharma has announced the appointment of Guy-Charles Fanneau de La Horie, MBA as its new Chief Executive Officer.
news
New nanoparticle has potential to treat ocular cancer
19 February 2016 | By Victoria White
Researchers have developed a new nanoparticle that uses a tumour cell's protective mechanism against itself - short-circuiting tumour cell metabolism and killing tumour cells...
news
Studies suggest major role for Regen’s NR2F6 target in controlling key immune functions
18 February 2016 | By Victoria White
The results demonstrate that suppression of NR2F6 in T-cells results in increased expression of key immune stimulatory proteins IL-17 and IL-18...
news
‘Extraordinary’ t-cell cancer therapy results generate excitement
16 February 2016 | By Victoria White
In one study, the engineered T-cells induced complete remission in 94% of patients with acute lymphoblastic leukaemia...
news
MGB Biopharma and Strathclyde to develop new MGB anti-infectives
16 February 2016 | By Victoria White
MGB Biopharma and the University of Strathclyde are to extend their existing collaboration to develop novel MGB anti-infectives...
news
Drug discovery crisis linked to bad technology choices
15 February 2016 | By Victoria White
Researchers say drug discovery processes are becoming unsustainably expensive despite huge technological advances because the wrong methods are being used…
news
Vaccines and alternatives can play a role in tackling drug-resistant infections
12 February 2016 | By Victoria White
The latest report from the Review on Antimicrobial Resistance says that vaccines and other alternatives can play a vital role in tackling the rise of drug-resistant infections...
news
Nimbolide shows potential as pancreatic cancer treatment
12 February 2016 | By Victoria White
Scientists tested nimbolide, natural extract derived from India's neem tree, against pancreatic cancer in cell lines and mice...
article
canSAR: a portal to Big Data for drug discovery
9 February 2016 | By Dr Bissan Al-Lazikani and Elizabeth Coker, The Institute of Cancer Research, London
Dr Bissan Al-Lazikani and Elizabeth Coker discuss canSAR: the first public domain example of Big Data for drug discovery...
news
Researchers uncover the role of PAD4 in cancers
8 February 2016 | By Victoria White
Peptidyl arginine deiminase 4 (PAD4) is a protein that plays a role in the development of inflammatory diseases like arthritis...
